How WPRX Partners Use Generics to Navigate Budget Pressures
Key takeaways:
Generic and biosimilar medicines saved the U.S. healthcare system $467 billion in 2024
Independent pharmacy gross margins fell to 18.2 percent in 2024, the lowest point in a decade
Distributors save the healthcare system up to $78 billion annually through supply chain efficiency
WPRX partners use generics as a practical, proven tool to manage cost pressure across the supply chain
Pharmacies and wholesalers manage today's budget pressure by leaning on generics as their primary cost-control lever. Generic and biosimilar medicines created $467 billion in savings in 2024, the most recent data available, with $3.4 trillion saved over the past ten years, according to the 2025 Savings Report.
This article looks at where that pressure lands for pharmacy and wholesaler partners, and how generics function as a working solution.
Pharmacy Margins Are Under Real Strain
Independent pharmacy represented a $103 billion marketplace in 2024, with gross profit margin falling to 18.2 percent, the lowest point in the 10-year lookback window tracked by the NCPA Digest.
Reimbursement compression and rising operating costs have squeezed margin on brand-name fills. Generic sourcing carries weight against this backdrop: 84 percent of prescriptions at independent pharmacies are filled with a generic drug, making the spread between acquisition cost and dispensing revenue one of the few margin levers pharmacies still control.
Wholesalers Manage A Different Kind Of Pressure
Distribution partners face their own cost dynamics: inventory carrying costs, procurement efficiency, and manufacturer contract terms all shape the bottom line.
Distributor services support 450,000 healthcare providers, pharmacies, and other sites of care by streamlining the supply chain, saving the healthcare system up to $78 billion annually. Predictable generic supply reduces exposure to pricing volatility and supports more consistent inventory planning, giving wholesale partners a stable foundation for pharmacy relationships.
How Does WPRX Support Affordability on Both Sides?
WPRX does our part by absorbing sourcing and supply complexity for pharmacy and wholesaler partners alike. Our catalog spans multiple therapeutic categories, giving partners a single point of contact for generic sourcing across their formulary needs. Manufacturer relationships behind the catalog are built for consistency, protecting partners from volatility that fragmented sourcing can introduce.
FAQs
Why are pharmacy margins declining even as prescription volume stays steady?
Reimbursement rates from PBMs and Medicare Part D have not kept pace with rising acquisition and operating costs. Independent pharmacy gross margins fell to 18.2 percent in 2024, the lowest point in a decade, even as prescription volume held relatively stable.
How do generics help offset wholesaler procurement costs?
Predictable generic supply reduces inventory carrying costs and shields wholesalers from sudden pricing swings. A consistent manufacturer relationship allows distributors to plan procurement more efficiently, supporting more stable pricing for downstream pharmacy partners.
Does lower generic pricing mean lower quality or reliability?
Generics comprised 90 percent of prescriptions filled in 2024 while accounting for only 12 percent of total spending, demonstrating that affordability and consistent supply quality coexist at scale across the U.S. generic drug market.
Are Generics the Strongest Tools Partners Have?
Budget pressure looks different for pharmacies and wholesalers, but generics give both a reliable, proven way to manage cost without sacrificing supply consistency or patient access. WPRX partners with pharmacies and wholesalers to put that affordability to work every day.
To discuss how the WPRX catalog can support your pharmacy or wholesale operation, contact a WPRX sales representative.
